Biosimilars Development Strategies: Fast to Market Approaches - Image 1

£123.50

CRC Press Biosimilars Development Strategies: Fast to Market Approaches

Name: Biosimilars Development Strategies: Fast to Market Approaches
Brand: CRC Press
Price: 123.5 GBP
Availability: InStock

European Union (EU)

This is the usual price. Wait for it to drop, or tell us your number.

£124 today · usual range £116–£124 · best ever £116

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 54 days · 54 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 54 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £124 (26 days, 48.1%)

Price range: £116 - £124

Price levels: 3 different prices over 54 days

Description

After 18 years since the first biosimilar was approved, a lot has changed, from the regulatory guidelines to the stakeholder perceptions about the safety and efficacy of biosimilars. However, the development costs remain high, preventing faster entry into markets with more than 200 choices. Analyzing the regulatory filings of all approved biosimilars in the US and EU, a deep analysis of the scientific principles, and continuous challenges to the regulatory authorities have made it possible to plan the development on a fast track. This book teaches how to cut the current time and cost by more than 70%, based on the author's hands-on experience. Features: Describes the emergence of biosimilars since the first publication of the recombinant engineering patent, as well as a listing of all approved recombinant products, their patent expiry and their adoption across the globe. Provides a better understanding of the safety and efficacy of approved biosimilars. Global approval requires accommodating guidelines and detailed planning to avoid redundancy as well as high costs. The basic expectations of the agencies are presented here. Presents a detailed analysis of all EU and FDA-approved products with a comparative analysis. Renowned author and entrepreneur in the field of drug discovery and production.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 1032517018
Category: Books > Subjects > Business, Finance & Law > Law > European Union (EU)
Domain: Amazon UK
Release Date: 15 July 2024
Listed Since: 25 January 2024

Barcode

No barcode data available

CRC Press Biosimilars Development Strategies: Fast to Market Approaches

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Biosimilarity: The FDA Perspective - CRC Press Book

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

ASHP Biosimilars and Biologics - Implementation and Monitoring

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

CRC Press - Biosimilar Drug Product Development Book

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Biopharmaceuticals: Challenges and Opportunities

Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide